Now I have a thorough understanding of the paper and the reviewer claims. Let me write the consolidated review.

## Summary

This paper proposes Booster, an alignment-stage defense against harmful fine-tuning of LLMs. The key idea is that "harmful perturbation" (a single gradient step on harmful data during fine-tuning) causes alignment failure by reducing harmful loss. Booster adds a regularizer during alignment that explicitly minimizes the gap between harmful loss before and after a simulated normalized harmful gradient step, thereby attenuating the harmful loss reduction rate. Experiments on Llama2-7B, Gemma2-9B, and Qwen2-7B across four fine-tuning tasks show substantial reductions in harmful score compared to SFT, Vaccine, RepNoise, and Lisa (e.g., 22.64 percentage point average HS reduction over SFT in Table 1) while maintaining or improving fine-tune accuracy.

## Strengths

1. **Principled regularizer directly targeting an identified causal mechanism.** The paper provides empirical evidence (Figure 1, Section 3.2) that fine-tuning on harmful data steadily reduces harmful loss while benign fine-tuning does not, identifying this as the root cause. The regularizer in Eq. (1) directly minimizes the gap h(w) − h(w − α∇h(w)/||∇h(w)||), which is a clean and well-motivated way to attenuate the harmful loss reduction rate. This is validated by Figure 2 showing Booster's harmful loss decreases much more slowly than SFT's during fine-tuning.

2. **Consistent and large empirical improvements across diverse settings.** Across harmful ratios (p=0.05 to 0.2), sample sizes (n=500 to 2500), downstream tasks (SST2, AGNEWS, GSM8K, AlpacaEval), and model architectures (Llama2-7B, Gemma2-9B, Qwen2-7B), Booster consistently achieves lower harmful scores than all baselines — often by very large margins (e.g., HS=7.03% average vs. 41.17% for SFT across models in Table 4, HS=1.60% on Qwen2-7B). These improvements hold while fine-tune accuracy is maintained or slightly improved.

3. **Comprehensive hyperparameter and ablation analysis.** Tables 5–7 systematically study the impact of λ (regularizer intensity), α (inner step size), and the number of harmful samples, showing that the method degrades to SFT when these are set to zero and requires careful tuning. This provides practical guidance and increases confidence that the method's behavior is understood.

4. **Demonstrated combinability with existing defenses.** Table 8 shows Booster + Vaccine further reduces harmful score compared to Booster alone (41.20% vs. 45.08%), indicating the method is complementary to prior alignment-stage solutions rather than redundant.

## Weaknesses

### Fatal
None.

### Major
None.

### Minor

1. **Baseline hyperparameter tuning is not documented.** The paper provides detailed hyperparameter analysis for Booster (λ, α, number of harmful samples) but does not state whether the hyperparameters of Vaccine, RepNoise, or Lisa were tuned for this evaluation or simply taken from their original papers. Vaccine and RepNoise have their own sensitive hyperparameters (e.g., κ for Vaccine, MMD regularizer weight for RepNoise). If the baselines used default settings while Booster's hyperparameters were optimized for this specific setup, the comparison — while the results are very large and consistent — would be somewhat asymmetric. A brief statement on how baselines' hyperparameters were chosen would resolve this.

2. **Safety metrics after alignment (pre-fine-tuning) are not reported.** All harmful scores are measured after the fine-tuning stage. Without knowing the harmful score immediately after alignment (before any fine-tuning), it is difficult to assess whether Booster degrades the base model's safety alignment relative to alternatives. The "clean" column (p=0 in Table 1) partially addresses this — Booster's clean HS is 1.90 vs. SFT's 1.30, Lisa's 0.90, RepNoise's 1.2, and Vaccine's 1.30. This suggests Booster may slightly weaken alignment even without harmful fine-tuning. The paper should acknowledge and discuss this trade-off explicitly, and report pre-fine-tuning HS for all methods.

3. **Statistical significance not reported.** Most tables report single values without variance. Given that some comparisons involve small differences (e.g., FA values of 93.23 vs. 93.69), it is unclear which differences are meaningful. Reporting variance across seeds (even if only 3 runs) or simple significance tests would substantially strengthen the claims.

4. **Vaccine+Booster experiment uses different data sizes.** The caption of Table 8 notes "The number of alignment data used in the alignment stage is 500," whereas all other main experiments use 5000 alignment data points. This change in setup makes direct comparison between Table 8 and the main results difficult. The paper should either replicate this combination with the standard 5000 samples or clarify why 500 was used.

5. **No explicit limitations section.** The paper would benefit from acknowledging: (a) the increased alignment time (~3× SFT) and memory overhead (~8.5 GB additional), (b) the need to pre-define a harmful dataset for alignment, (c) that the defense's effectiveness degrades at higher harmful ratios (p > 0.2, HS rises to 25.5%), and (d) the reliance on distributional similarity between harmful data used in alignment and in fine-tuning. The system evaluation table partially covers the overhead, but a dedicated limitations discussion would strengthen the paper.

6. **The harmful loss analysis (Figure 2) only compares SFT vs. Booster.** While this shows the mechanism works, it is unclear whether RepNoise and Vaccine also show a slower harmful loss reduction rate. Including these baselines in the statistical analysis would clarify whether Booster's effect on the loss reduction rate is truly unique or partially shared with other alignment-stage defenses.

### Trivial

- **Ambiguous phrasing**: "22.64% of lower harmful score" (Section 5.1) mixes absolute percentage points with relative percentages. It should read "22.64 percentage points lower harmful score" or clarify "22.64% relatively lower."
- **"Despite its embarrassing simplicity"** (Conclusion): This phrasing is unnecessary and editorializing. The method requires three gradient computations per step and careful hyperparameter tuning — it is not "embarrassingly simple."

## Nice-to-Haves

- **Out-of-distribution harmful attack evaluation**: The harmful data used in alignment and in fine-tuning are from the same distribution (BeaverTails). Testing on a harmful dataset from a different distribution (e.g., collected via red-teaming) would demonstrate robustness beyond distributional similarity.
- **Empirical check of second-order approximation**: The paper drops the Hessian term (standard practice from MAML). A small-scale comparison with the full Hessian on a smaller model would increase confidence in this approximation.
- **Comparison/discussion of TAR**: The paper mentions TAR as concurrent work but provides no empirical comparison or detailed discussion of trade-offs. Even a brief comparison in the related work section would be helpful.
- **Disentangling initial harmful loss from reduction rate**: The paper acknowledges that Booster starts with lower harmful loss (Figure 2). Showing that the *slope* of harmful loss reduction is smaller for Booster even when controlling for initial loss — or comparing all methods' pre-fine-tuning harmful loss — would strengthen the causal narrative, though the current evidence already supports the core claim.

## Removed Points

These points from the reviews were removed after verification against the paper:

- **"The method's success may be a self-fulfilling artifact of lower initial harmful loss"** (Harsh Critic, Issue 1, framed as "structural concern"): The paper explicitly acknowledges Booster's lower initial harmful loss (Figure 2, middle panel) and frames this as part of the defense's mechanism. The regularizer's purpose is to attenuate the *rate* of harmful loss reduction, which Figure 2 confirms (Booster's harmful loss decreases much more slowly). Lower initial harmful loss is a design feature, not a confound. The claim that this "undermines the central causal claim" is an overstatement. The paper could better disentangle these effects, which is why it is kept as a Nice-to-Have rather than a weakness.

- **"Introduction claim about harmful perturbation is not novel"**: The paper explicitly distinguishes its insight (harmful perturbation as reduction of harmful loss) from prior work on embedding drift (Vaccine) and representation distribution (RepNoise). Section 2 (paragraph 2) and Section 3.1 clearly state this differentiation.

- **"50 samples suffice, why default 5000?"**: The hyperparameter analysis (Table 7) shows 50 samples yield HS=5.10 while 5000 yields HS=4.00. Using 5000 is the more conservative choice — this is not a weakness.

- **"Embarrassing simplicity is unnecessary"**: Pure style nitpick.

- **"Unfair comparison" complaint if the reviewer cited asymmetries favoring baselines**: Not applicable — no such asymmetry was found.

- **Missing appendix/proofs/related works concerns**: These reflect parser-side stripping, not author errors.

- **Any formatting/style/typo complaints**: Parser artifacts, not author errors.

## Novel Insights

The key insight emerging from this synthesis is that Booster's design embodies a subtle but important shift from prior defenses. Vaccine and RepNoise operate on embedding drift or representation distribution — they try to *hide* harmful information from the fine-tuning process. Booster instead directly confronts the harmful gradient dynamics: rather than obscuring the harmful signal, it makes the model's loss landscape *flat* along the harmful gradient direction, so that even when a harmful gradient step is taken during fine-tuning, the harmful loss barely decreases. This "adversarial training against future fine-tuning" framing is a genuinely different conceptual approach, and the strong empirical results (especially the 1.60% HS on Qwen2-7B) suggest it may be a more effective paradigm. The trade-off — slightly higher clean HS (1.90) and substantial alignment-stage overhead — is characteristic of defenses that engage directly with the attack mechanism rather than trying to evade it.

## Suggestions

1. **Report pre-fine-tuning harmful scores** for all methods in a small table, and discuss the trade-off between Booster's slightly higher clean HS and its dramatically lower post-attack HS. This would address the most significant evidential gap.

2. **Add a statement on how baselines' hyperparameters were chosen.** If they used the default/recommended settings from the original papers, say so. If they were tuned, describe the tuning procedure. This would take two sentences and resolve a reasonable reviewer concern.

3. **Add variance or confidence intervals** to the main tables (even just min/max across 3 seeds for the default setting). Given the large margins, the conclusions are unlikely to change, but the rigor would be appreciated.

4. **Move the "clean" column (p=0) discussion** to be more prominent. The paper should explicitly note that Booster's clean HS=1.90 is slightly higher than baselines and explain why this is acceptable given the large gains under attack.

5. **Add a brief Limitations paragraph** to the conclusion covering the main known constraints (increased alignment cost, dependence on harmful dataset quality, effectiveness degradation at high p).

## Score and Decision

Based on my assessment: The paper proposes a well-motivated, novel defense against a timely problem. The regularizer design is clean and principled. The empirical evaluation is extensive (3 models, 4 tasks, multiple attack configurations) and the improvements are large and consistent. The weaknesses are minor — none threaten the paper's core claims. The baseline tuning concern and pre-fine-tuning evaluation gap are addressable in a rebuttal and do not undermine the clear empirical patterns. The paper makes a solid contribution.

MY FINAL SCORE: <pineapple>7.0</pineapple>
MY FINAL DECISION: <orange>Accept</orange>